Literature DB >> 11488631

Quantitative analysis of 5-oxo-6,8,11,14-eicosatetraenoic acid by electrospray mass spectrometry using a deuterium-labeled internal standard.

W S Powell1, D Boismenu, S P Khanapure, J Rokach.   

Abstract

5-Oxo-6,8,11,14-eicosatetraenoic acid (5-oxo-ETE), a metabolite of arachidonic acid formed by the 5-lipoxygenase pathway, is a potent eosinophil chemoattractant that may be an important mediator in asthma. To further investigate the physiological and pathological roles of 5-oxo-ETE we have developed a mass spectrometric assay employing a tetradeuterated analog (5-oxo-[11,12,14,15-(2)H]ETE) as an internal standard. Collision-induced dissociation of the quasimolecular anion of 5-oxo-[11,12,14,15-(2)H]ETE (m/z 321) resulted in the formation of a major ion at m/z 207 that retained all four deuterium atoms. Measurement of the ratio of ions at m/z 203 (endogenous 5-oxo-ETE) and m/z 207 permitted quantitation of this compound by liquid chromatography-mass spectrometry-mass spectrometry using multiple reaction monitoring. The resulting assay was highly sensitive (< or =20 pg/sample) and selective, enabling detection of the amount of 5-oxo-ETE produced by as few as 10,000 neutrophils. This assay should permit measurement of 5-oxo-ETE in biological fluids, enabling evaluation of its role in asthma and other inflammatory diseases. Copyright 2001 Academic Press.

Entities:  

Mesh:

Substances:

Year:  2001        PMID: 11488631     DOI: 10.1006/abio.2001.5206

Source DB:  PubMed          Journal:  Anal Biochem        ISSN: 0003-2697            Impact factor:   3.365


  2 in total

1.  Airway epithelial cells synthesize the lipid mediator 5-oxo-ETE in response to oxidative stress.

Authors:  Karl-Rudolf Erlemann; Chantal Cossette; Sylvie Gravel; Alain Lesimple; Gue-Jae Lee; Goutam Saha; Joshua Rokach; William S Powell
Journal:  Free Radic Biol Med       Date:  2006-12-14       Impact factor: 7.376

2.  5-Oxo-ETE receptor antagonists.

Authors:  Vivek Gore; Pranav Patel; Chih-Tsung Chang; Sashikala Sivendran; Namin Kang; Yannick P Ouedraogo; Sylvie Gravel; William S Powell; Joshua Rokach
Journal:  J Med Chem       Date:  2013-04-26       Impact factor: 7.446

  2 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.